Mylan N.V. (MYL) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Mylan N.V. (MYL) over the last 10 years.
|Medical||Medical - Generic Drugs||$21.184B||$11.077B|
|Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.|